Researchers from University of Melbourne Detail New Studies and Findings in the Area of Prostate Cancer [Ga-68-prostate-specific Membrane Antigen (Psma) Pet/ct As a Clinical Decision-making Tool In Biochemically Recurrent Prostate Cancer].

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Abstract:
      We prospectively investigated the management impact of Ga-68-PSMA PET/CT imaging in men with BCR, with the aim of identifying baseline clinicopathological predictors for management change." Keywords: Melbourne; Australia; Australia and New Zealand; Biochemicals; Cancer; Chemicals; Drugs and Therapies; Health and Medicine; Oncology; Prostate Cancer; Prostatic Neoplasms; Radiotherapy EN Melbourne Australia Australia and New Zealand Biochemicals Cancer Chemicals Drugs and Therapies Health and Medicine Oncology Prostate Cancer Prostatic Neoplasms Radiotherapy 1153 1153 1 10/09/23 20231013 NES 231013 2023 OCT 10 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Imaging Week -- Investigators discuss new findings in Oncology - Prostate Cancer. Melbourne, Australia, Australia and New Zealand, Biochemicals, Cancer, Chemicals, Drugs and Therapies, Health and Medicine, Oncology, Prostate Cancer, Prostatic Neoplasms, Radiotherapy. [Extracted from the article]
    • Abstract:
      Copyright of Medical Imaging Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)